Gene-Disorder Association · Article
Gene
VDRVitamin D Receptor
×
First reported
1993
Supporting publications
46
Manually curatedApproved treatment annotated
Association Review
In brief
The association between VDR (Vitamin D Receptor) and Osteoporosis is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
9
Compounds
9
Trials
265of 2,507 via VDR compounds
Publications
46
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
21 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Phenotype
Clinical features
1 clinical feature
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access
06
Interventions
Therapeutics
9 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
07
Human studies
Clinical trials
2,507 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
46 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
09
Provenance
References & sources
17 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access